Wednesday, 30 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Supha Pharmachem Ltd

NSE: ROXY · BSE: 539561 · Commercial Services & Supplies · 3 announcements

Share price
₹0.26
Market cap
₹22.93 Cr
Revenue (annual)
₹222.5 Cr
Net profit (annual)
₹1.53 Cr
P/E (TTM)
-10.6×Sector 42.2×
Promoter holding
1.13%+0.00% QoQ
FII holding
1.70%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

Time

3 announcements with these filters

15:53 IST BSE
Insolvency Petition

Supha Pharmachem Insolvency Petition

Supha Pharmachem disclosed an NCLAT order disposing of an insolvency appeal. The order prevents the Committee of Creditors from voting on resolutions until June 29, 2026.

21:49 IST BSE
Insolvency Petition

Supha Pharmachem Insolvency Petition

Supha Pharmachem Limited announced outcomes of its first CoC meeting held on April 14, 2026. The CoC approved the appointment of Mr. Raju Mangilal Marshiya as Resolution Professional, replacing the interim professional. Other approved items include ratification of IRP remuneration, legal advisor fees, and the estimated six-month budget under the CIRP.

18:55 IST BSE
Insolvency Petition

Supha Pharmachem Insolvency Petition

Supha Pharmachem Limited (formerly Remedium Lifecare) provided a CIRP update, disclosing total claims received of ₹123.75 Crore. An Interim Resolution Professional has been appointed by NCLT Mumbai, and the first Committee of Creditors meeting is scheduled for April 14, 2026. The company noted non-cooperation from suspended directors regarding records and control.

Value
₹123.8 Cr